TrialBlood cancer journal2021

Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).

Sagar Lonial et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.